Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Recommended
What to know about Labor Day and its history
Recommended
The sun now sets before 8 p.m. Will we ever do away with the time change?
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Cannara Biotech Inc
(OP:
LOVFF
)
0.5372
UNCHANGED
Streaming Delayed Price
Updated: 2:57 PM EDT, Aug 29, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
0.5372
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
0.5372
Today's Range
0.5372 - 0.5372
52wk Range
0.4010 - 0.7751
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Cannara Biotech Reports 6% YoY Drop In Q3 Gross Profit, 22% Revenue Increase As It Enhances Sales Force And Infrastructure
July 23, 2024
Vertically integrated cannabis company Cannara Biotech Inc. (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB0) announced on Tuesday its fiscal third quarter 2024 financial and operating results for the three and...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannara Biotech Reports Q3 2024 Financial Results
July 23, 2024
From
Cannara Biotech (Québec) Inc.
Via
GlobeNewswire
Performance
YTD
-13.99%
-13.99%
1 Month
+21.02%
+21.02%
3 Month
-3.55%
-3.55%
6 Month
-25.51%
-25.51%
1 Year
-29.70%
-29.70%
More News
Read More
Cannabis Slowdown In Canada: Analyst Spotlights What Still Sells And Where The Money Is Going
June 03, 2024
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannara Biotech Reports 51% YoY Revenue Increase In Q2, Wider Net Loss
May 01, 2024
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
This Cannabis Producer Reports It Is Able to Deliver Some Of The Highest Quality Product To Market At Some Of The Most Competitive Prices
December 20, 2023
Via
News Direct
Topics
Cannabis
Exposures
Cannabis
The 7 Most Undervalued Cannabis Stocks to Buy in December
December 14, 2023
Via
InvestorPlace
Topics
Cannabis
Exposures
Cannabis
This Cannabis Producer Reports It Is Able to Deliver Some Of The Highest Quality Product To Market At Some Of The Most Competitive Prices
December 07, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Bearish Sentiment Across The Cannabis Space - Check Full Movers For August 21, 2023
August 21, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
7 Smoking-Hot 420 Stocks to Buy in 2023
August 17, 2023
Via
InvestorPlace
Topics
Cannabis
Exposures
Cannabis
Cannabis Stock Movers For August 10, 2023
August 10, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannara Biotech Q3 FY23 Net Revenue Grows 57% YoY, What About Adjusted EBITDA?
July 27, 2023
Via
Benzinga
Cannabis Stock Gainers And Losers From July 25, 2023
July 25, 2023
Via
Benzinga
Cannabis Stock Gainers And Losers From August 4, 2023
August 04, 2023
Via
Benzinga
Cannara Biotech Secures An Additional $10M In Non-Dilutive Capital With Its Lead Credit Provider, BMO Commercial Banking
May 04, 2023
Via
Benzinga
Cannara Biotech Q2 FY23 Revenue Grows 76% YoY To $9.6M, Here Are The Details
April 24, 2023
Via
Benzinga
Marijuana Stock Movers For August 1, 2023
August 01, 2023
Via
Benzinga
Olymbec Investments Increases Its Ownership In Cannara Biotech
February 10, 2023
Via
Benzinga
Cannara Biotech Q1 Revenue Grows 57% YoY To $7.7M, What About Adjusted EBITDA?
January 23, 2023
Via
Benzinga
Cannabis Stock Movers For July 27, 2023
July 27, 2023
Via
Benzinga
Cannara Biotech Q4 Revenue Grows 84% YoY To $8.9M
November 28, 2022
Via
Benzinga
Cannara Biotech Enters Into The British Columbia Cannabis Market And Launches New Products
September 20, 2022
Via
Benzinga
Cannara Biotech Signs An Exclusive Brand Partnership With Exotic Genetix In Canada
August 03, 2022
Via
Benzinga
Cannara Biotech Revenue Grows 41% YoY, Here Are The Details
July 27, 2022
Via
Benzinga
Cannara Biotech Closes $50 Million Credit Facility Led By BMO Commercial Banking
June 02, 2022
Via
Benzinga
Cannara Biotech Revenues Grew 229% To $7.4M In Q2 2022 YoY
April 27, 2022
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.